Literature DB >> 11118615

Alternative splicing and gene structure of the transforming growth factor beta-activated kinase 1.

C E Dempsey1, H Sakurai, T Sugita, F Guesdon.   

Abstract

We have identified a fourth splice variant of the TGF beta-activated kinase (TAK1), called TAK1-d, and identified an error in the previously published TAK1-c sequence. Our data shows that the c and d variants encode proteins whose carboxyl ends differ markedly from those of variants a and b. Analysis of the human TAK1 gene sequence, located at 6q16.1-q16.3, shows that the coding sequence is organised in 17 exons. The four splice variants result from alternative splicing of exons 12 and 16, the reading frame of exon 17 being determined by the presence or absence of exon 16. Study of the relative levels of expression of the four splice variants showed significant variations between tissues. Our evidence suggests that the alternative splicing of the TAK1 mRNA may have important functional implications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118615     DOI: 10.1016/s0167-4781(00)00258-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Expression analysis of the TAB2 protein in adult mouse tissues.

Authors:  C Orelio; E Dzierzak
Journal:  Inflamm Res       Date:  2007-03       Impact factor: 4.575

2.  MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.

Authors:  Kelsey L McNew; William J Whipple; Anita K Mehta; Trevor J Grant; Leah Ray; Connor Kenny; Anurag Singh
Journal:  Mol Cancer Res       Date:  2016-09-21       Impact factor: 5.852

3.  Sequence-specific activation of TAK1-D by short double-stranded RNAs induces apoptosis in NCI-H460 cells.

Authors:  Reinhard Kodym; Elisabeth Kodym; Micheal D Story
Journal:  RNA       Date:  2008-01-29       Impact factor: 4.942

4.  Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.

Authors:  Emma M Wade; Philip B Daniel; Zandra A Jenkins; Aideen McInerney-Leo; Paul Leo; Tim Morgan; Marie Claude Addor; Lesley C Adès; Debora Bertola; Axel Bohring; Erin Carter; Tae-Joon Cho; Hans-Christoph Duba; Elaine Fletcher; Chong A Kim; Deborah Krakow; Eva Morava; Teresa Neuhann; Andrea Superti-Furga; Irma Veenstra-Knol; Dagmar Wieczorek; Louise C Wilson; Raoul C M Hennekam; Andrew J Sutherland-Smith; Tim M Strom; Andrew O M Wilkie; Matthew A Brown; Emma L Duncan; David M Markie; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2016-07-15       Impact factor: 11.025

Review 5.  Alternative splicing in the NF-kappaB signaling pathway.

Authors:  Joshua R Leeman; Thomas D Gilmore
Journal:  Gene       Date:  2008-07-22       Impact factor: 3.688

6.  Cell-type-resolved alternative splicing patterns in mouse liver.

Authors:  Peng Wu; Donghu Zhou; Weiran Lin; Yanyan Li; Handong Wei; Xiaohong Qian; Ying Jiang; Fuchu He
Journal:  DNA Res       Date:  2018-01-08       Impact factor: 4.458

7.  TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance.

Authors:  Veenu Tripathi; Jee-Hye Shin; Christina H Stuelten; Ying E Zhang
Journal:  Oncogene       Date:  2019-01-09       Impact factor: 9.867

8.  Regulation of TAK1/TAB1-mediated IL-1β signaling by cytoplasmic PPARβ/δ.

Authors:  Josefine Stockert; Alexander Wolf; Kerstin Kaddatz; Evelyn Schnitzer; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Michael Kracht; Rolf Müller
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.